Back to mobile site

More on BNTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+700.0% Growth)
- Ratings (7.0 Score)

Upcoming Events

- Earnings (11/3/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BioNTech SE (NQ:BNTX)
Delayed: 103.76 --0 (-0%)
Prev. Close $103.76  
Open$103.76 
52 Wk High$ 
52 Wk Low$ 
Day High$103.76 
Day Low$103.76 
P/E N/A  
EPS$ 
Volume15,369 

Friends, Peers and Foes (?): 0A3M, PFE, MRNA, NVAX, AZN (more...)

Sep 8, 2026 04:36 AM BMO Capital Downgrades BioNTech (BNTX) to Market Perform
Aug 31, 2026 07:08 AM BioNTech (BNTX) PT Lowered to $136 at Canaccord
Aug 28, 2026 09:46 AM BioNTech drops 10% on mRNA trial failure, highlighting Moderna contrast
Aug 28, 2026 09:09 AM BioNTech ends colorectal cancer mRNA therapy trial early
Aug 28, 2026 09:06 AM Form 6-K BioNTech SE For: Aug 28
Aug 27, 2026 04:55 PM Form 6-K BioNTech SE For: Aug 27
Aug 27, 2026 04:30 PM FDA approves Pfizer-BioNTech XFG-targeted Covid-19 vaccine
Aug 27, 2026 04:30 PM Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
Aug 26, 2026 09:20 AM A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
Aug 20, 2026 07:37 AM Form 6-K BioNTech SE For: Aug 20
View All Articles

Entities mentioned with BNTX

View All Entities